Epidemiología del cáncer de próstata: análisis comparativo de los principales cánceres urológicos
Cancer presents as a leading cause of mortality worldwide, with its incidence exhibiting an upward trend attributable to population aging, the implementation of novel diagnostic tools, and the availability of innovative therapies. In males, prostate cancer stands out as one of the neoplasms with the highest incidence and prevalence, further associated with an elevated mortality rate, excluding skin cancer. A detailed understanding of the incidence, mortality, and particularly, the disease burden of this neoplasm is of paramount relevance, as it allows for the formulation and implementation of measures and strategies in health policies aimed at mitigating the negative impact on both public health and national economies. Globally in 2021, 432,463 deaths due to prostate cancer were recorded, whereas in Mexico the figure reached 8,860. In Mexico and worldwide, prostate cancer is a highly prevalent neoplasm and represents a substantial disease burden. Timely intervention is necessary to mitigate its impact.
Authors
- Iván Delgado‐Enciso (ORCID: https://orcid.org/0000-0001-9848-862X)
- José Guzmán-Esquivel (ORCID: https://orcid.org/0000-0002-6727-0051)
- Hannah Priscila Guzmán Solórzano
Institutions
- Hospital General De Zona (MX)
- Universidad de Colima (MX)
Publication Details
- Journal
- Revista Mexicana de Urología
- Published
- 2025-05-19
- DOI
- https://doi.org/10.48193/cpthsn35
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52